Jim Taylor President and CEO, 2CTech Corp, San Francisco, USA.

0114-601-ATA-Jim Taylor

Previously, Jim as held the positions of Head of Research & Development and Head of Marketing of Carl Zeiss Meditec AG, and was the Chief Executive Officer and President of Carl Zeiss Meditec, Inc. until joining Oraya Therapeutics. A former US Navy submarine commander, Jim has had a wide range of management experiences, and brings them together in this column for The Ophthalmologist.

Content by Jim Taylor:

Subspecialties Retina

Quantum Leap?

12/05/2019 | Jim Taylor

Electrical stimulation of neural responses can significantly improve outcomes for retinitis pigmentosa patients

teaser of 0114-601

Business & Profession Professional Development

Re-engineering Healthcare

01/22/2014 | Jim Taylor

For all of us associated with healthcare, it should be apparent that our world is on the cusp of a significant change.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Ophthalmologist magazine

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

if the user is a new user
if the user is not logged in

Once confirmed we store a cookie to not show the disclaimer again.